search
Back to results

Rehabilitation by Eccentric Exercise in Heart Failure Patients (REX-HF)

Primary Purpose

Chronic Heart Failure Patient, Rehabilitation Program

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Eccentric rehabilitation sessions
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Heart Failure Patient focused on measuring Heart failure, eccentric, exercise, rehabilitation program, exercise testing, 6 min. walk test

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient with systolic chronic heart failure
  • Patients aged 18 to 75 years
  • Referred for participation in the 5-week rehabilitation program
  • At a time distance from an acute coronary syndrome or myocarditis (less than 3 months old) and clinically stabilized.
  • Beneficiary or affiliated with social security coverage

Exclusion Criteria:

  • All the usual criteria considered contra-indicated for cardiac exercise rehabilitation according to the consensus recommendations ( REF)
  • Non-stabilized acute coronary syndrome
  • Decompensated heart insufficiency
  • Stage IV NYHA
  • Severe, uncontrolled disturbances in ventricular rhythm
  • Presence of an intracardiac thrombus with high risk of embolism
  • Presence of pericardial effusion of medium to high importance
  • Recent history of thrombophlebitis with or without pulmonary embolism
  • Obstacle to severe and / or symptomatic left ventricular ejection
  • Any progressive inflammatory and / or infectious condition
  • Severe and symptomatic pulmonary arterial hypertension
  • Inability to perform physical activity
  • Reversible heart disease
  • Patients undergoing circulatory assistance
  • Patients taking blood thinner medication (except Kardegic-type aggregates and direct oral anticoagulants)
  • Patients with known allergy to Xylocaine
  • Pregnant or lactating women
  • Women of childbearing age without contraception
  • Patient under tutorship, curatorship or deprived of liberty

Sites / Locations

  • Chu Clermont-Ferrand

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

Classical exercise training modality in concentric mode (CON)

experimental, active group (ECC)

Arm Description

Description: Control group, usual medical care according to the rehabilitation recommendations

Patients perform a mixed program combining eccentric pedalling session with the usual sessions

Outcomes

Primary Outcome Measures

6 min. walk test (6-WT)
6 min. walk test (6-WT)
6 min. walk test (6-WT)
6 min. walk test (6-WT)

Secondary Outcome Measures

Time up and go test (TUGT)
Test that evaluates seated transfers, standing, walking and changes of direction.
Time up and go test (TUGT)
Test that evaluates seated transfers, standing, walking and changes of direction.
Quadriceps isometric muscular strength
The maximum muscle strength of the quadriceps (dominant limb) will be measured on a bench according to the instructions
Quadriceps isometric muscular strength
The maximum muscle strength of the quadriceps (dominant limb) will be measured on a bench according to the instructions
Gait speed test
Test that evaluate walking speed over 4 meters
Gait speed test
Test that evaluate walking speed over 4 meters
Results of the incremental tests
Peak VO2
Results of the incremental tests
Peak VO2
Body composition measurements
fat body mass
Body composition measurements
lean body mass
Body composition measurements
fat body mass
Body composition measurements
lean body mass
Muscle Biopsie
mitochondrial and histo-biochemical functionality from muscle biopsies
Muscle Biopsie
mitochondrial and histo-biochemical functionality from muscle biopsies
Metabolomic analysis
identification of specific blood and muscle biomarkers in response to retraining
Metabolomic analysis
identification of specific blood and muscle biomarkers in response to retraining

Full Information

First Posted
October 8, 2018
Last Updated
June 9, 2023
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Clinique Médicale Cardio-Pneumologique de Durtol
search

1. Study Identification

Unique Protocol Identification Number
NCT03716778
Brief Title
Rehabilitation by Eccentric Exercise in Heart Failure Patients
Acronym
REX-HF
Official Title
Enhanced Effectiveness of Combined Eccentric and Concentric Exercise Over Traditional Cardiac Exercise Rehabilitation Program in Patients With Chronic Heart Failure: a Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Terminated
Why Stopped
This premature end of the study is due to the lack of human resources and the fact that the forceps used to perform the biopsies for this study have not been marketed since January 2023.
Study Start Date
November 9, 2018 (Actual)
Primary Completion Date
May 26, 2022 (Actual)
Study Completion Date
May 26, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Clinique Médicale Cardio-Pneumologique de Durtol

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
As part of the regular rehabilitation program for chronic heart failure (CHF) patients, the addition of dynamic eccentric endurance (ECC) exercise sessions to the conventional concentric cycling program (CON) would enable greater gains in functional capacity that the CON alone. Furthermore, in the case of severe heart failure, results of conventional exercise rehabilitation remains limited on account of the poor physical fitness and deconditioning. Dynamic ECC has been shown to enhance muscle mass and improve muscle strength in subjects with functional limitations comparable to those in CHF, but to date reports on effects on muscle endurance and overall functional capacity remain scarce or non-existent. Investigator hypothesize that a combination of these two types of training will allow both an improvement in strength and oxidative muscle capacities. These benefits must be objectified at the level of the walking distance covered in 6 min (6-WT).
Detailed Description
Investigator hypothesize that the combination of CON and ECC forms of endurance exercise will potentiate peripheral muscle and cardio-circulatory adaptations. All sessions, regardless of the modality, will be performed at the same percentage of the concentric peakVO2. Sessions performed in ECC mode will induce a mechanical overload. The ECC training of such intensity and duration seemingly having little or no effect on mitochondrial muscle adaptations, the maintenance of conventional training will allow stimulation of the aerobic endurance component. A synergistic effect is expected from the combination of the two modalities; the muscle strength gain induced by ECC allowing to sustained greater cycling workloads yet compatible with the cardio-circulatory capabilities of patients with CHF and more specifically their exercise cardiac output adjustment. Investigator chose to assess the extent of benefits through functional capacity tests reflecting adaptation of both the aerobic (endurance capacity) and anaerobic (muscle strength) components of adaptive response, namely, 1) 6 min. walk test (6-WT), 2) time up and go test (TUGT), 3) quadriceps isometric muscular strength (IMS) and gait speed test. The study is a prospective, open, controlled and randomized study in two parallel groups carried out in a single center. Patients will be included in the study if: i) they are referred to the cardiac rehabilitation center for the 5-week training program, ii) they meet the inclusion criteria and iii) they provide their signed consent. Patients will be followed for 5 weeks, the duration of the cardiac rehabilitation program. They will benefit from the standard evaluation of any CHF patient referred for rehabilitation including an initial 12-lead ECG, a trans-thoracic cardiac ultrasound assessment and a cycling exercise stress test with gas exchange analysis and non-invasive measurement of cardiac output using a bio-impedance device. A standard biological blood analysis will be performed for NFS-platelets, blood electrolytes, CRP, NTproBNP, nutritional status with albumin and pre-albumin. All subjects will perform 5 exercise sessions per week on a cycle ergometer. As per randomization outcome, the "intervention" group will perform three of the five weekly sessions in ECC mode (the other two in CON) while the control group will perform the five weekly sessions in CON mode. The intensity of the cycling will be the same in both groups as determined from the initial cycling incremental test targeted to correspond to the VO2 associated with the ventilatory threshold.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Heart Failure Patient, Rehabilitation Program
Keywords
Heart failure, eccentric, exercise, rehabilitation program, exercise testing, 6 min. walk test

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
23 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Classical exercise training modality in concentric mode (CON)
Arm Type
Other
Arm Description
Description: Control group, usual medical care according to the rehabilitation recommendations
Arm Title
experimental, active group (ECC)
Arm Type
Experimental
Arm Description
Patients perform a mixed program combining eccentric pedalling session with the usual sessions
Intervention Type
Other
Intervention Name(s)
Eccentric rehabilitation sessions
Intervention Description
ECC cycling will be conducted using a commercially available ECC motor-driven ergometer. Intensity and duration are progressively increased during the first five sessions in order to minimize the extent of exercise-induced muscle soreness. The subjects will perform five sessions of endurance training on cycle ergometer per week. Each session lasting 30 minutes will be achieved at an intensity corresponding to the pre-determined CON ventilatory threshold. In the ECC group, 3 sessions of ECC (Monday, Wednesday and Friday) and two session of concentric (Tuesday and Thursday) cycling will be carried out each week. In the control group CON all sessions will be achieved using the traditional pedaling mode.
Primary Outcome Measure Information:
Title
6 min. walk test (6-WT)
Description
6 min. walk test (6-WT)
Time Frame
at day 1
Title
6 min. walk test (6-WT)
Description
6 min. walk test (6-WT)
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Secondary Outcome Measure Information:
Title
Time up and go test (TUGT)
Description
Test that evaluates seated transfers, standing, walking and changes of direction.
Time Frame
at day 1
Title
Time up and go test (TUGT)
Description
Test that evaluates seated transfers, standing, walking and changes of direction.
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Title
Quadriceps isometric muscular strength
Description
The maximum muscle strength of the quadriceps (dominant limb) will be measured on a bench according to the instructions
Time Frame
at day 1
Title
Quadriceps isometric muscular strength
Description
The maximum muscle strength of the quadriceps (dominant limb) will be measured on a bench according to the instructions
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Title
Gait speed test
Description
Test that evaluate walking speed over 4 meters
Time Frame
at day 1
Title
Gait speed test
Description
Test that evaluate walking speed over 4 meters
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Title
Results of the incremental tests
Description
Peak VO2
Time Frame
at day 1
Title
Results of the incremental tests
Description
Peak VO2
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Title
Body composition measurements
Description
fat body mass
Time Frame
at day 1
Title
Body composition measurements
Description
lean body mass
Time Frame
at day 1
Title
Body composition measurements
Description
fat body mass
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Title
Body composition measurements
Description
lean body mass
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Title
Muscle Biopsie
Description
mitochondrial and histo-biochemical functionality from muscle biopsies
Time Frame
at day 1
Title
Muscle Biopsie
Description
mitochondrial and histo-biochemical functionality from muscle biopsies
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)
Title
Metabolomic analysis
Description
identification of specific blood and muscle biomarkers in response to retraining
Time Frame
at day 1
Title
Metabolomic analysis
Description
identification of specific blood and muscle biomarkers in response to retraining
Time Frame
at the end of the rehabilitation program (at the end of the 5 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with systolic chronic heart failure Patients aged 18 to 75 years Referred for participation in the 5-week rehabilitation program At a time distance from an acute coronary syndrome or myocarditis (less than 3 months old) and clinically stabilized. Beneficiary or affiliated with social security coverage Exclusion Criteria: All the usual criteria considered contra-indicated for cardiac exercise rehabilitation according to the consensus recommendations ( REF) Non-stabilized acute coronary syndrome Decompensated heart insufficiency Stage IV NYHA Severe, uncontrolled disturbances in ventricular rhythm Presence of an intracardiac thrombus with high risk of embolism Presence of pericardial effusion of medium to high importance Recent history of thrombophlebitis with or without pulmonary embolism Obstacle to severe and / or symptomatic left ventricular ejection Any progressive inflammatory and / or infectious condition Severe and symptomatic pulmonary arterial hypertension Inability to perform physical activity Reversible heart disease Patients undergoing circulatory assistance Patients taking blood thinner medication (except Kardegic-type aggregates and direct oral anticoagulants) Patients with known allergy to Xylocaine Pregnant or lactating women Women of childbearing age without contraception Patient under tutorship, curatorship or deprived of liberty
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruddy RICHARD
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chu Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
31558450
Citation
Plaquevent-Hostache G, Touron J, Costes F, Perrault H, Clerfond G, Cuenin C, Moisa A, Pereira B, Boiteux MC, Eschalier R, Richard R. Effectiveness of combined eccentric and concentric exercise over traditional cardiac exercise rehabilitation programme in patients with chronic heart failure: protocol for a randomised controlled study. BMJ Open. 2019 Sep 26;9(9):e028749. doi: 10.1136/bmjopen-2018-028749.
Results Reference
derived

Learn more about this trial

Rehabilitation by Eccentric Exercise in Heart Failure Patients

We'll reach out to this number within 24 hrs